Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLC

Clinical trial NCT05458726 · UNKNOWN

Trial details

NCT number: NCT05458726
Sponsor: Peking Union Medical College
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

EGFR T790M Osimertinib Non-small Cell Lung Cancer ddPCR

Start date: 2020-09-15
Primary completion: 2022-07-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.